|
Name |
1-Phenylpentan-3-one
|
Molecular Formula | C11H14O | |
IUPAC Name* |
1-phenylpentan-3-one
|
|
SMILES |
CCC(=O)CCC1=CC=CC=C1
|
|
InChI |
InChI=1S/C11H14O/c1-2-11(12)9-8-10-6-4-3-5-7-10/h3-7H,2,8-9H2,1H3
|
|
InChIKey |
GLVAUXMKXKUEEA-UHFFFAOYSA-N
|
|
Synonyms |
1-Phenylpentan-3-one; 1-Phenyl-3-pentanone; 20795-51-1; 1-Phenyl-pentan-3-one; 3-Pentanone, 1-phenyl-; AI3-21915; VEP8CR4F7Z; EINECS 244-045-6; 5phenylpentan-3-one; UNII-VEP8CR4F7Z; SCHEMBL1874; DTXSID10174882; ACT05705; ZINC2166503; MFCD00027025; AKOS009389875; DB-045375; CS-0245904; FT-0638048; EN300-313191; (4-ETHYL-BIPHENYL-4-YLMETHYL)-HYDRAZINE; 795P511; A814906
|
|
CAS | 20795-51-1 | |
PubChem CID | 88701 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 162.23 | ALogp: | 2.3 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 1 |
Heavy Atoms: | 12 | QED Weighted: | 0.663 |
Caco-2 Permeability: | -4.401 | MDCK Permeability: | 0.00002490 |
Pgp-inhibitor: | 0.04 | Pgp-substrate: | 0.118 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.009 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.972 | Plasma Protein Binding (PPB): | 77.96% |
Volume Distribution (VD): | 1.183 | Fu: | 11.43% |
CYP1A2-inhibitor: | 0.795 | CYP1A2-substrate: | 0.797 |
CYP2C19-inhibitor: | 0.513 | CYP2C19-substrate: | 0.305 |
CYP2C9-inhibitor: | 0.102 | CYP2C9-substrate: | 0.276 |
CYP2D6-inhibitor: | 0.037 | CYP2D6-substrate: | 0.641 |
CYP3A4-inhibitor: | 0.028 | CYP3A4-substrate: | 0.32 |
Clearance (CL): | 8.903 | Half-life (T1/2): | 0.886 |
hERG Blockers: | 0.063 | Human Hepatotoxicity (H-HT): | 0.198 |
Drug-inuced Liver Injury (DILI): | 0.145 | AMES Toxicity: | 0.032 |
Rat Oral Acute Toxicity: | 0.041 | Maximum Recommended Daily Dose: | 0.072 |
Skin Sensitization: | 0.347 | Carcinogencity: | 0.084 |
Eye Corrosion: | 0.273 | Eye Irritation: | 0.974 |
Respiratory Toxicity: | 0.122 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000004 | 0.667 | D0P2GK | 0.605 | ||||
ENC000597 | 0.651 | D00DZN | 0.511 | ||||
ENC000217 | 0.622 | D0P9AC | 0.500 | ||||
ENC000596 | 0.581 | D05OIS | 0.462 | ||||
ENC000693 | 0.581 | D0R1CR | 0.457 | ||||
ENC000216 | 0.581 | D0T3LF | 0.442 | ||||
ENC000215 | 0.578 | D05BMG | 0.442 | ||||
ENC000598 | 0.578 | D07ONP | 0.429 | ||||
ENC000218 | 0.550 | D0U0RZ | 0.422 | ||||
ENC000203 | 0.541 | D0R0UJ | 0.417 |